Tânia Ferreira-Gonçalves

Ms. Tânia Ferreira-Gonçalves

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Dept. of Pharmacy, Pharmacology and Health Technologies, Universidade de Lisboa., Lisbon, Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
Tânia Ferreira-GonçalvesTânia Ferreira-Gonçalves
Tânia Ferreira-Gonçalves
Constantin CaruntuConstantin Caruntu
Constantin Caruntu
Monica NeaguMonica Neagu
Monica Neagu
Catarina ReisCatarina Reis
Catarina Reis
Firouzeh SabriFirouzeh Sabri
Firouzeh Sabri
RSRosana Simón-Vázquez
Rosana Simón-Vázquez
The unique physicochemical properties of aerogels have made them an attractive class of materials for biomedical applications such as drug delivery, regenerative medicine, and wound healing. Their low density, high porosity, and ability to regulate the pore structure makes aerogels ideal nano/micro-structures for loading of drugs and active biomolecules. As a result of this, the number of in vitro and in vivo studies on the therapeutic efficacy of these porous materials has increased substantially in recent years and continues to be an area of great interest. However, data about their in vivo performance and safety is limited. Studies have shown that polymer-based, silica-based and some hybrid aerogels are generally regarded as safe but given that studies on the acute, subacute, and chronic toxicity for the majority of aerogel types is missing, more work is still needed. This review presents a comprehensive summary of different biomedical applications of aerogels proposed to date as well as new and innovative applications of aerogels in other areas such as decontamination. We have also reviewed their biological effect on cells and living organisms with a focus on therapeutic efficacy and overall safety (in vivo and in vitro).

31 March 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JLJoana Lopes
Joana Lopes
Tânia Ferreira-GonçalvesTânia Ferreira-Gonçalves
Tânia Ferreira-Gonçalves
LALia Ascensão
Lia Ascensão
AVAna Viana
Ana Viana
Lina CarvalhoLina Carvalho
Lina Carvalho
Catarina ReisCatarina Reis
Catarina Reis
In recent years, gold nanoparticles (AuNPs) have aroused the interest of many researchers due to their unique physicochemical and optical properties. AuNPs are being explored in a variety of biomedical fields, either in diagnostics or therapy, particularly for localized thermal ablation of cancer cells after light irradiation. Besides the promising therapeutic potential of AuNPs, their safety constitutes a highly important issue for any medicine or medical device. For this reason, in the present work, the production and characterization of physicochemical properties and morphology of AuNPs coated with two different materials (hyaluronic and oleic acids (HAOA) and bovine serum albumin (BSA)) were firstly performed. Based on the above importantly referred issue, the in vitro safety of developed AuNPs was evaluated in healthy keratinocytes, human melanoma, breast, pancreatic and glioblastoma cancer cells, as well as in a three-dimensional human skin model. Ex vivo and in vivo biosafety assays using, respectively, human red blood cells and Artemia salina were also carried out. HAOA-AuNPs were selected for in vivo acute toxicity and biodistribution studies in healthy Balb/c mice. Histopathological analysis showed no significant signs of toxicity for the tested formulations. Overall, several techniques were developed in order to characterize the AuNPs and evaluate their safety. All these results support their use for biomedical applications.

4 January 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
Tânia Ferreira-GonçalvesTânia Ferreira-Gonçalves
Tânia Ferreira-Gonçalves
Maria Manuela GasparMaria Manuela Gaspar
Maria Manuela Gaspar
João M. P. CoelhoJoão M. P. Coelho
João M. P. Coelho
VMVanda Marques
Vanda Marques
AVAna Viana
Ana Viana
Catarina ReisCatarina Reis
Catarina Reis
Breast cancer is a high-burden malignancy for society, whose impact boosts a continuous search for novel diagnostic and therapeutic tools. Among the recent therapeutic approaches, photothermal therapy (PTT), which causes tumor cell death by hyperthermia after being irradiated with a light source, represents a high-potential strategy. Furthermore, the effectiveness of PTT can be improved by combining near infrared (NIR) irradiation with gold nanoparticles (AuNPs) as photothermal enhancers. Herein, an alternative synthetic method using rosmarinic acid (RA) for synthesizing AuNPs is reported. The RA concentration was varied and its impact on the AuNPs physicochemical and optical features was assessed. Results showed that RA concentration plays an active role on AuNPs features, allowing the optimization of mean size and maximum absorbance peak. Moreover, the synthetic method explored here allowed us to obtain negatively charged AuNPs with sizes favoring the local particle accumulation at tumor site and maximum absorbance peaks within the NIR region. In addition, AuNPs were safe both in vitro and in vivo. In conclusion, the synthesized AuNPs present favorable properties to be applied as part of a PTT system combining AuNPs with a NIR laser for the treatment of breast cancer.

31 July 2020 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
Eduardo CostaEduardo Costa
Eduardo Costa
Tânia Ferreira-GonçalvesTânia Ferreira-Gonçalves
Tânia Ferreira-Gonçalves
GCGonçalo Chasqueira
Gonçalo Chasqueira
ACAntónio S. Cabrita
António S. Cabrita
Isabel V. FigueiredoIsabel V. Figueiredo
Isabel V. Figueiredo
Catarina ReisCatarina Reis
Catarina Reis
Breast cancer is one of the most common cancers worldwide, which makes it a very impactful malignancy in the society. Breast cancers can be classified through different systems based on the main tumor features and gene, protein, and cell receptors expression, which will determine the most advisable therapeutic course and expected outcomes. Multiple therapeutic options have already been proposed and implemented for breast cancer treatment. Nonetheless, their use and efficacy still greatly depend on the tumor classification, and treatments are commonly associated with invasiveness, pain, discomfort, severe side effects, and poor specificity. This has demanded an investment in the research of the mechanisms behind the disease progression, evolution, and associated risk factors, and on novel diagnostic and therapeutic techniques. However, advances in the understanding and assessment of breast cancer are dependent on the ability to mimic the properties and microenvironment of tumors in vivo, which can be achieved through experimentation on animal models. This review covers an overview of the main animal models used in breast cancer research, namely in vitro models, in vivo models, in silico models, and other models. For each model, the main characteristics, advantages, and challenges associated to their use are highlighted.

30 March 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
JLJoana Lopes
Joana Lopes
Tânia Ferreira-GonçalvesTânia Ferreira-Gonçalves
Tânia Ferreira-Gonçalves
Isabel V. FigueiredoIsabel V. Figueiredo
Isabel V. Figueiredo
Cecilia MP RodrigugesCecilia MP Rodriguges
Cecilia MP Rodriguges
HFHugo Alexandre Ferreira
Hugo Alexandre Ferreira
Catarina ReisCatarina Reis
Catarina Reis
The global impact of cancer emphasizes the importance of developing innovative, effective and minimally invasive therapies. In the context of superficial cancers, the development of a multifunctional nanoparticle-based system and its in vitro and in vivo safety and efficacy characterization are, herein, proposed as a proof-of-concept. This multifunctional system consists of gold nanoparticles coated with hyaluronic and oleic acids, and functionalized with epidermal growth factor for greater specificity towards cutaneous melanoma cells. This nanoparticle system is activated by a near-infrared laser. The characterization of this nanoparticle system included several phases, with in vitro assays being firstly performed to assess the safety of gold nanoparticles without laser irradiation. Then, hairless immunocompromised mice were selected for a xenograft model upon inoculation of A375 human melanoma cells. Treatment with near-infrared laser irradiation for five minutes combined with in situ administration of the nanoparticles showed a tumor volume reduction of approximately 80% and, in some cases, led to the formation of several necrotic foci, observed histologically. No significant skin erythema at the irradiation zone was verified, nor other harmful effects on the excised organs. In conclusion, these assays suggest that this system is safe and shows promising results for the treatment of superficial melanoma.

6 March 2023 in Gels
Verified
Journal Article
Open access
PDF file
PFPedro Francisco
Pedro Francisco
MAMariana Neves Amaral
Mariana Neves Amaral
ANAfonso Neves
Afonso Neves
Tânia Ferreira-GonçalvesTânia Ferreira-Gonçalves
Tânia Ferreira-Gonçalves
AVAna Viana
Ana Viana
Catarina ReisCatarina Reis
Catarina Reis
Presently, skin burns are considered one of the main public health problems and lack therapeutic options. In recent years, silver nanoparticles (AgNPs) have been widely studied, playing an increasingly important role in wound healing due to their antibacterial activity. This work is focused on the production and characterization of AgNPs loaded in a Pluronic® F127 hydrogel, as well as assessing its antimicrobial and wound-healing potential. Pluronic® F127 has been extensively explored for therapeutic applications mainly due to its appealing properties. The developed AgNPs had an average size of 48.04 ± 14.87 nm (when prepared by method C) and a negative surface charge. Macroscopically, the AgNPs solution presented a translucent yellow coloration with a characteristic absorption peak at 407 nm. Microscopically, the AgNPs presented a multiform morphology with small sizes (~50 nm). Skin permeation studies revealed that no AgNPs permeated the skin after 24 h. AgNPs further demonstrated antimicrobial activity against different bacterial species predominant in burns. A chemical burn model was developed to perform preliminary in vivo assays and the results showed that the performance of the developed AgNPs loaded in hydrogel, with smaller silver dose, was comparable with a commercial silver cream using higher doses. In conclusion, hydrogel-loaded AgNPs is potentially an important resource in the treatment of skin burns due to their proven efficacy by topical administration.